Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

CareDx, Inc.

CIK 1217234 CDNA·Services · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K/A
  2. Material weakness 10-Q +62d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Material weakness Filing comparison

CareDx, Inc. reported internal control effective again after a material weakness

Material weakness in internal control Internal control reported effective

The weakness was first reported on 2024-05-09 — 719 days and 6 annual reports before this one.

… controls and procedures and internal control over financial reporting were effective as of March 31, 2026, we anticipate that we will continue to expend resources, including accounting-related costs and significant management oversight to continue to improve our internal control over financial reporting. 68 Table of Contents As discussed in Item 9A “Controls and Procedures” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, a material weakness existed in our internal control over…
Evidence
Current state
effective
Current state label
Internal control reported effective
Direction
remediated
Prior filed
2025-11-04
Prior form
10-Q
Prior state
material_weakness
Prior state label
Material weakness in internal control
Remediation stated
Yes
Severity
normal
Source
Item 9A internal control conclusion, compared with the prior filing
Weakness annual reports
6
Weakness days reported
719
Weakness first reported
2024-05-09
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.
Finance chief departure high Filing comparison

CareDx, Inc.'s Chief Financial Officer departed with no named successor

Evidence
Interim only
No
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
high
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.